Curi Bio ^Private

Curi Bio is a biotechnology company that integrates human stem cells, systems biology, and data analytics to accelerate the discovery of new medicines. Their platform focuses on developing human iPSC-derived tissues, particularly in the areas of cardiac and musculoskeletal diseases. By using human stem cells, Curi Bio is able to create more accurate and predictive models for studying disease mechanisms and testing potential drug candidates. Their goal is to increase the predictive accuracy of the preclinical drug development process. Curi Bio offers best-in-class products and technical support to help researchers succeed in their drug discovery efforts.